The deamination of noradrenaline and 5-hydroxytryptamine by rat brain and heart monoamine oxidase and their inhibition by cimoxatone, toloxatone and MD 770222

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  1983-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00512469PMID 6633672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cimoxatone Is a Reversible Tight‐Binding Inhibitor of the A Form of Rat Brain Monoamine Oxidase

  1983cited by this paper
• The Metabolism of Dopamine by Both Forms of Monoamine Oxidase in the Rat Brain and Its Inhibition by Cimoxatone

  1983cited by this paper
• The deamination of n‐pentylamine by monoamine oxidase and a semicarbazide‐sensitive amine oxidase of rat heart

  1983cited by this paper
• Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat.

  1983cited by this paper
• Monoamine oxidase type A: differences in selectivity towards l-norepinephrine compared to serotonin.

  1982cited by this paper
• Deamination of 5‐Hydroxytryptamine by Both Forms of Monoamine Oxidase in the Rat Brain

  1982cited by this paper
• Differences in the preferential deamination of l-norepinephrine, dopamine and serotonin by MAO in rodent and primate brain

  1981cited by this paper
• MAO-A and MAO-B in the superior cervical ganglion and in the nictitating membrane of the cat.

  1981cited by this paper
• Characteristics of the Inhibition of Rat Brain Monoamine Oxidase In Vitro by MD780515

  1981cited by this paper
• The activities of monoamine oxidase-A and-B, succinate dehydrogenase and acid phosphatase in the rat brain after hemitransection

  1981cited by this paper
• Characterization of eight biogenic indoleamines as substrates for type A and type B monoamine oxidase.

  1981cited by this paper
• Essential metals and metallothionein in cadmium-induced thymic atrophy and splenomegaly.

  1981cited by this paper
• Substrate Selectivity of Type A and Type B Monoamine Oxidase in Rat Brain

  1980cited by this paper
• Studies on the subcellular localization of monoamine oxidase types A and B and its importance for the deamination of dopamine in the rat brain.

  1980cited by this paper
• [Monoamine oxidase and its inhibition (author's transl)].

  1980cited by this paper
• Some factors influencing the metabolism of benzylamine by type A and B monoamine oxidase in rat heart and liver

  1980cited by this paper
• The deamination of isoamylamine by monamine oxidase in mitochondrial preparations from rat liver and heart: a comparison with phenylethylamine.

  1980cited by this paper
• The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons.

  1980cited by this paper
• Serotonin oxidation by type B MAO of rat brain.

  1980cited by this paper
• The inhibition or rat heart type A monoamine oxidase by clorgyline as a method for the estimation of enzyme active centers.

  1979cited by this paper
• Substrate specificity of monoamine oxidase in pig liver mitochondria.

  1979cited by this paper
• Selective influences of age and thyroid hormones on Type A monoamine oxidase of the rat heart

  1979cited by this paper
• An explanation for deamination of phenylethylamine by multiple types of monoamine oxidase.

  1979cited by this paper
• Monoamine oxidase A and B: a useful concept?

  1978cited by this paper
• EVIDENCE FOR DOPAMINE DEAMINATION BY BOTH TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAIN in vivo AND FOR THE DEGREE OF INHIBITION OF ENZYME NECESSARY FOR INCREASED FUNCTIONAL ACTIVITY OF DOPAMINE AND 5‐HYDROXYTRYPTAMINE

  1977cited by this paper
• Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase.

  1977cited by this paper
• Subcellular localization of types A and B monoamine oxidase in rat brain.

  1977cited by this paper
• A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes.

  1974cited by this paper
• Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain.

  1973cited by this paper
• Some puzzling pharmacological effects of monoamine oxidase inhibitors.

  1972cited by this paper
• Monoamine oxidase in sympathetic nerves: a transmitter specific enzyme type

  1971cited by this paper
• Further studies on the inhibition of monoamine oxidase by M and B 9302 (clorgyline). I. Substrate specificity in various mammalian species.

  1969cited by this paper
• Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

  1968cited by this paper
• RADIOISOTOPIC ASSAY FOR MONOAMINE OXIDASE DETERMINATIONS IN HUMAN PLASMA.

  1964cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Non-cytochrome P450 enzymes involved in the oxidative metabolism of xenobiotics: Focus on the regulation of gene expression and enzyme activity.

  2021cites this paper
• RISK ASSESSMENTS 11

  2014cites this paper
• Study examining the inhibition of human monoamine oxidase (MAO) by the new psychoactive substance 5-(2-aminopropyl)indole (5-IT). Annex 2 to the “5-(2-Aminopropyl)indole (5-IT): Report on the risk assessment of 5-(2-aminopropyl)indole in the framework of the Council Decision on new psychoactive subs

  2014cites this paper
• 5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO).

  2014cites this paper
• Social Deficits and Perseverative Behaviors, but not Overt Aggression, in MAO-A Hypomorphic Mice

  2011cites this paper
• Acute effects of moclobemide and deprenyl on 5-HT synthesis rates in the rat brain: An autoradiographic study.

  2006cites this paper
• Myocardial H2O2 production in the unanaesthetized rat Influence of fasting, myocardial load and inhibition of superoxide dismutase and monoamine oxidase

  2005cites this paper
• Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia

  2004cites this paper
• Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone

  2004cites this paper
• Differential substrate specificity of monoamine oxidase in the rat heart and renal cortex.

  2003cites this paper
• Monoamin-Oxidase-Hemmer

  2002cites this paper
• Relevance of reversible inhibitors of monoamine oxidase type A and of reuptake inhibition for noradrenaline turnover

  1995cites this paper
• Platelet MAO-B activity as a marker of behavioural characteristics in dementia disorders

  1994cites this paper
• Contribution of amine oxidases to the metabolism of xenobiotics.

  1994cites this paper
• Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase‐A inhibitor, and oral tyramine in healthy subjects

  1992cites this paper
• The new generation of monoamine oxidase inhibitors.

  1992cites this paper
• Determination of levels of biogenic amines and their metabolites and both forms of monoamine oxidase in prefrontal cortex of aged rats.

  1990cites this paper
• [Acute toloxatone poisoning. Apropos of 122 cases].

  1990cites this paper
• Alterations of serotonin neurotransmission and inhibition of mouse-killing behavior: III. Effects of minaprine, CM 30366 and SR 95191.

  1989cites this paper
• [The role of changes in catalytic properties of brain monoamine oxidase in the response to extreme conditions (review of the literature)].

  1989cites this paper
• Interactions of monoamine oxidase with substrates and inhibitors

  1989cites this paper
• Alterations of serotonin neurotransmission and inhibition of mouse killing behavior: II. Effects of selective and reversible monoamine oxidase inhibitors of type A.

  1988cites this paper
• Basic and clinical aspects of the activity of the new monoamine oxidase inhibitors.

  1988cites this paper
• SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.

  1987cites this paper
• The activity of the neuronal and extraneuronal catecholamine-metabolizing enzymes of the perfused rat heart

  1987cites this paper
• Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements.

  1987cites this paper
• Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons

  1986cites this paper
• The oxidation of adrenaline and noradrenaline by the two forms of monoamine oxidase from human and rat brain.

  1986cites this paper
• Effect of the antidepressant minaprine on both forms of monoamine oxidase in the rat.

  1986cites this paper
• Age‐related changes in monoamine oxidase and semicarbazide‐sensitive amine oxidase activities of rat aorta

  1985cites this paper
• On-line radiochemical assay for monoamine oxidase utilizing high-performance liquid chromatography.

  1984cites this paper
• Selective inhibitors of monoamine oxidase A and B: Biochemical, pharmacological, and clinical properties

  1984cites this paper
• Monoamine oxidase and semicarbazide-sensitive amine oxidase in spontaneously hypertensive and in normotensive control rats.

  1984cites this paper
• Reversed-phase high-performance liquid chromatographic separation of 14C-labelled toloxatone and its metabolites.

  1984cites this paper